165 related articles for article (PubMed ID: 26856603)
1. Primate-specific miR-603 is implicated in the risk and pathogenesis of Alzheimer's disease.
Zhang C; Lu J; Liu B; Cui Q; Wang Y
Aging (Albany NY); 2016 Feb; 8(2):272-90. PubMed ID: 26856603
[TBL] [Abstract][Full Text] [Related]
2. Relationship between single nucleotide polymorphisms in the 3'UTR of amyloid precursor protein and risk of Alzheimer's disease and its mechanism.
Zhou Q; Luo L; Wang X; Li X
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30914454
[No Abstract] [Full Text] [Related]
3. Correlation Between SIRT2 3'UTR Gene Polymorphism and the Susceptibility to Alzheimer's Disease.
Shen Y; Chen L; Zhang S; Xie L
J Mol Neurosci; 2020 Jun; 70(6):878-886. PubMed ID: 32124252
[TBL] [Abstract][Full Text] [Related]
4. A SNP site in pri-miR-124 changes mature miR-124 expression but no contribution to Alzheimer's disease in a Mongolian population.
Qi L; Hu Y; Zhan Y; Wang J; Wang BB; Xia HF; Ma X
Neurosci Lett; 2012 Apr; 515(1):1-6. PubMed ID: 22430032
[TBL] [Abstract][Full Text] [Related]
5. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation.
Wang X; Liu P; Zhu H; Xu Y; Ma C; Dai X; Huang L; Liu Y; Zhang L; Qin C
Brain Res Bull; 2009 Oct; 80(4-5):268-73. PubMed ID: 19683563
[TBL] [Abstract][Full Text] [Related]
6. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor.
Wang H; Liu J; Zong Y; Xu Y; Deng W; Zhu H; Liu Y; Ma C; Huang L; Zhang L; Qin C
Brain Res; 2010 Oct; 1357():166-74. PubMed ID: 20709030
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide identification of microRNA-related variants associated with risk of Alzheimer's disease.
Ghanbari M; Ikram MA; de Looper HWJ; Hofman A; Erkeland SJ; Franco OH; Dehghan A
Sci Rep; 2016 Jun; 6():28387. PubMed ID: 27328823
[TBL] [Abstract][Full Text] [Related]
8. A single nucleotide polymorphism in primary-microRNA-146a reduces the expression of mature microRNA-146a in patients with Alzheimer's disease and is associated with the pathogenesis of Alzheimer's disease.
Zhang B; Wang A; Xia C; Lin Q; Chen C
Mol Med Rep; 2015 Sep; 12(3):4037-4042. PubMed ID: 26095531
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression analysis of adult-onset Drosophila Alzheimer's disease model.
Kong Y; Wu J; Yuan L
Curr Alzheimer Res; 2014; 11(9):882-91. PubMed ID: 25274109
[TBL] [Abstract][Full Text] [Related]
10. miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer's disease.
Delay C; Grenier-Boley B; Amouyel P; Dumont J; Lambert JC
Alzheimers Res Ther; 2016 May; 8(1):20. PubMed ID: 27215977
[TBL] [Abstract][Full Text] [Related]
11. A complex crosstalk between polymorphic microRNA target sites and AD prognosis.
Mallick B; Ghosh Z
RNA Biol; 2011; 8(4):665-73. PubMed ID: 21659796
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
Müller M; Kuiperij HB; Claassen JA; Küsters B; Verbeek MM
Neurobiol Aging; 2014 Jan; 35(1):152-8. PubMed ID: 23962497
[TBL] [Abstract][Full Text] [Related]
15. Screening of microRNAs associated with Alzheimer's disease using oxidative stress cell model and different strains of senescence accelerated mice.
Zhang R; Zhang Q; Niu J; Lu K; Xie B; Cui D; Xu S
J Neurol Sci; 2014 Mar; 338(1-2):57-64. PubMed ID: 24423585
[TBL] [Abstract][Full Text] [Related]
16. The miRNome of Alzheimer's disease: consistent downregulation of the miR-132/212 cluster.
Pichler S; Gu W; Hartl D; Gasparoni G; Leidinger P; Keller A; Meese E; Mayhaus M; Hampel H; Riemenschneider M
Neurobiol Aging; 2017 Feb; 50():167.e1-167.e10. PubMed ID: 27816213
[TBL] [Abstract][Full Text] [Related]
17. Downregulated serum miR-223 servers as biomarker in Alzheimer's disease.
Jia LH; Liu YN
Cell Biochem Funct; 2016 Jun; 34(4):233-7. PubMed ID: 27027823
[TBL] [Abstract][Full Text] [Related]
18.
Wang J; Zhou Y; Yang Y; Gao X; Liu Z; Hong G; Yao L; Yin J; Gu X; Li K
Aging (Albany NY); 2021 May; 13(10):13954-13967. PubMed ID: 33982673
[TBL] [Abstract][Full Text] [Related]
19. miR-519a-3p, found to regulate cellular prion protein during Alzheimer's disease pathogenesis, as a biomarker of asymptomatic stages.
Jácome D; Cotrufo T; Andrés-Benito P; Lidón L; Martí E; Ferrer I; Del Río JA; Gavín R
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167187. PubMed ID: 38653354
[TBL] [Abstract][Full Text] [Related]
20. A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis.
Liu ME; Liao YC; Lin RT; Wang YS; Hsi E; Lin HF; Chen KC; Juo SH
Atherosclerosis; 2013 May; 228(1):161-7. PubMed ID: 23497787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
